Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
LGVN | Longeveron Inc. | Director | $64.9K | +$11.7K | +21.9% | Dec 2, 2024 |
PCSA | Processa Pharmaceuticals, Inc. | Director | Sep 3, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|